gsk256066
Showing 1 - 10 of 10
Rhinitis, Allergic, Seasonal Trial in Berlin (GSK256066)
Completed
- Rhinitis, Allergic, Seasonal
- GSK256066
-
Berlin, GermanyGSK Investigational Site
Jul 17, 2018
Pulmonary Disease, Chronic Obstructive Trial in Hannover (GSK256066, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK256066
- Placebo
-
Hannover, Niedersachsen, GermanyGSK Investigational Site
Aug 4, 2017
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GSK256066, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK256066
- Placebo
-
Tallinn, Estonia
- +14 more
Jul 25, 2017
Asthma Trial in Wellington, George, Bloemfontein (GSK256066)
Completed
- Asthma
- GSK256066
-
Wellington, New Zealand
- +2 more
Jun 22, 2017
Rhinitis, Allergic, Seasonal Trial in Vienna (GSK256066, fluticasone propionate)
Completed
- Rhinitis, Allergic, Seasonal
- GSK256066
- fluticasone propionate
-
Vienna, AustriaGSK Investigational Site
Nov 2, 2016
Rhinitis, Allergic, Seasonal, Seasonal Allergic Rhinitis Trial in Vienna (GSK256066)
Completed
- Rhinitis, Allergic, Seasonal
- Seasonal Allergic Rhinitis
- GSK256066
-
Vienna, AustriaGSK Investigational Site
Apr 14, 2015
Allergic Rhinitis, Rhinitis, Allergic, Seasonal Trial in Vienna (GSK256066, azelastine HCl)
Completed
- Allergic Rhinitis
- Rhinitis, Allergic, Seasonal
- GSK256066
- azelastine hydrochloride
-
Vienna, AustriaGSK Investigational Site
May 31, 2012
Asthma Trial in Wellington (GSK256066)
Completed
- Asthma
- GSK256066
-
Wellington, New ZealandGSK Investigational Site
May 31, 2012
Rhinitis, Allergic, Seasonal, Seasonal Allergic Rhinitis Trial in Vienna (GSK256066)
Completed
- Rhinitis, Allergic, Seasonal
- Seasonal Allergic Rhinitis
- GSK256066
-
Vienna, AustriaGSK Investigational Site
May 31, 2012
Asthma, Mild Asthma Trial in Manchester, London (GSK256066)
Completed
- Asthma
- Mild Asthma
- GSK256066
-
Manchester, Lancashire, United Kingdom
- +1 more
May 31, 2012